Society of Hematologic Oncology

Society of Hematologic Oncology

Share

Become a member of SOHO today for free! SSAUNQ 2024 | November 22, 2024 | Virtual SOHO is led by a Board of Directors with six voting members.

SOHO is the only international society for clinicians, scientists & related professionals who specialize in the research & treatment of hematologic malignancies. The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic maligna

Operating as usual

Is SVR linked to survival benefit in pacritinib-treated patients with myelofibrosis? 01/28/2025

Is SVR linked to survival benefit in pacritinib-treated patients with myelofibrosis?

Is SVR linked to survival benefit in pacritinib-treated patients with myelofibrosis? A study found that “pacritinib may offer a unique survival advantage” for patients with myelofibrosis (MF) and thrombocytopenia who achieve any spleen volume reduction (SVR). The study was led by Helen Ajufo, MD, of Washington University School of Medicine in St. Louis, Missouri, and published i...

Dr. Garcia-Manero discusses mature data on luspatercept’s efficacy in MDS 01/23/2025

Dr. Garcia-Manero discusses mature data on luspatercept’s efficacy in MDS

Watch the video:

Dr. Garcia-Manero discusses mature data on luspatercept’s efficacy in MDS Guillermo Garcia-Manero MD, of the University of Texas MD Anderson Cancer Center, discusses long-term data from the COMMANDS trial, highlighting the use of luspatercept (Reblozyl) as a first-line treatment for lower-risk myelodysplastic syndromes (MDS). After 1.5 years, one-third of patients maintai...

01/22/2025

We're proud to announce and welcome our newest SOHO Corporate Partner, Autolus! Learn more about Autolus at www.autolus.com

Learn more about SOHO Corporate Partnerships👉 http://soho.click/partner

01/14/2025

Subscribe to http://sohoinsider.com, the one and only official news source of the Society of Hematologic Oncology. (Please note that Blood Cancers Today is no longer affiliated with SOHO.)

Presence of circulating lymphoma cells a significant adverse risk factor in DLBCL 01/09/2025

Presence of circulating lymphoma cells a significant adverse risk factor in DLBCL

Presence of circulating lymphoma cells a significant adverse risk factor in DLBCL The largest study to date evaluating the impact of circulating lymphoma cells (CL) on outcomes in patients with newly diagnosed de novo diffuse large B-cell lymphoma (DLBCL) found that presence of CL at diagnosis was associated with inferior response rates and survival compared to those without CL.....

Researchers call for ‘evidence-based’ driving restrictions for patients treated with CAR-T therapy 01/08/2025

Are driving restrictions too stringent for patients being treated with ? This analysis takes a closer look. What do you think?

Researchers call for ‘evidence-based’ driving restrictions for patients treated with CAR-T therapy Driving restrictions for blood cancer patients undergoing chimeric antigen receptor (CAR)-T cell therapy may need reconsideration, according to research presented by Rahul Banerjee, MD, FACP, of the University of Washington Fred Hutchinson Cancer Center, at the 66th ASH Annual Meeting and Exposition...

Aspiring hem/onc fellows discuss myeloma research, SOHO Annual Meeting opportunities 01/07/2025

Still deciding if is the right path for you? Join us at (soho.click/2025) to get inspired! Still don't believe us? Hear what past SOHO attendees have to say about the meeting's impact on their career:

Aspiring hem/onc fellows discuss myeloma research, SOHO Annual Meeting opportunities Wajeeha Aiman, MD, and Muhammad Ashar Ali, MD, discuss the benefits of attending the SOHO Annual Meeting in Houston, Texas, for early-career healthcare professionals. Drs. Aiman and Ashar also discuss their SOHO poster presentation on multiple myeloma and measurable residual disease negativity.

NCI’s myeloMATCH precision medicine initiative pushes the envelope in myeloid leukemia care 01/03/2025

“This is about more than AML. It’s about creating a model for how we can use science, technology, and collaboration to revolutionize cancer care,” Harry Erba said in an interview with SOHO Insider on the MyeloMATCH initiative.

Read the story here:

NCI’s myeloMATCH precision medicine initiative pushes the envelope in myeloid leukemia care A new National Cancer Institute (NCI) initiative seeks to redefine the standard for personalized cancer care in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). Known as MyeloMATCH—(Myeloid Malignancies Molecular Analysis for Therapy Choice)—the ambitious program integrates molec...

Zamto-cel shows promise in interim results from phase 2 pivotal study 01/01/2025

Zamto-cel shows promise in interim results from phase 2 pivotal study Miltenyi Biotec

Zamto-cel shows promise in interim results from phase 2 pivotal study SOHO Insider spoke with Toon Overstijns, CEO of Miltenyi Biomedicine, and Dr. Anna Wijatyk, CMO (USA) of Miltenyi Biomedicine, at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition held in San Diego, California. In the video interview, Overstijns and discuss interim results....

SOHO president looks back on 2024 12/27/2024

We are in the final days of #2024 and we are in a celebratory mood 🥳 . Hear from our current SOHO President all about what we have accomplished this past year!

SOHO president looks back on 2024 For SOHO, 2024 was a year of firsts and continued growth of the society worldwide. Current SOHO President Phillip Scheinberg, MD, PhD, chief of hematology at the Hospital A Beneficência Portuguesa de São Paulo in Brazil, looks back on the year and what is in store for 2025.

Introducing SOHO Insider 12/16/2024

We are so excited to announce the launch of our new digital and print publication SOHO Insider. We will be covering the latest news in . Check out what our EIC Sagar Lonial, MD, has to say in this video

Introducing SOHO Insider Sagar Lonial, MD, of Emory University, introduces SOHO Insider the new digital and print publication from the Society of Hematologic Oncology (SOHO). As the editor-in-chief and a past SOHO president, Dr. Lonial shares insights into this exciting launch in a video filmed during the 66th American Soci...

12/09/2024

Stay tuned for our in roundtable!!

Photos from Society of Hematologic Oncology's post 12/07/2024

We are ready for . Stop by our booth 35 in the nonprofit section to say hello and sign up for membership!

12/05/2024

We are here at ! Visit us at booth 35 in the nonprofit section to get one of these little guys when you sign up for free membership. Grand Hyatt Manchester San Diego amazing view!

11/22/2024

📢 starts in less than 30 minutes. There is still time to register at http://soho.click/ssaunq. SOHO members register for free. Registration includes 3 months of on-demand access!🥳

Want your school to be the top-listed School/college in The Woodlands?

Click here to claim your Sponsored Listing.

About the Society

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders. Since that time, nearly 3,000 members have joined the society from around the globe.

SOHO is led by a Board of Directors with eight voting members. In addition, an outstanding group of clinician-scientists have been assembled to serve on the Steering Committee to provide guidance and direction in the continued development of SOHO.

Two additional committees, Scientific and Education, are responsible for abstract review and the scientific program of the annual meetings, respectively.

“Clinical Lymphoma, Myeloma & Leukemia,” a peer-reviewed journal published by Elsevier, is the official journal of SOHO. It is available online free-of-charge to SOHO members and at a discounted rate in printed form (click the 'Sign Up' button to become a SOHO member).

The SOHO Sixth Annual Meeting is scheduled for September 12-15, 2018 at the Hilton Americas-Houston in Houston, Texas. The society expects approximately 1,200 physicians and related professionals to attend the 3.5-day event. (go to soho2018.org for more information, abstract submissions and registration).

Videos (show all)

Why join the Society of Hematologic Oncology?Rami Komrokji and Phillip Scheinberg discuss at #Hemo2024.https://youtu.be/...
Drs. Kantarjian and Jain talk about #CLL, #BTK inhibitors, and more during #SOHO2024 on YouTube at https://buff.ly/3UHEH...
Happening now: Leukemia satellite symposium
Full house for Dr. Garcia-Manero’s talk at #SEHH2024 in Mallorca!
Drs. Kantarjian and Litzow at #soho2024 discuss the phase 3 discuss the #E1910 trial published in the #NEJM Watch here: ...
Drs. Kantarjian and Craddock discussing the state of #AML therapy from chemotherapy to transplant. Watch the full interv...
Congratulations to the EHA 2024 Contest Winner: Dr. Jose Gabriel Chavez Sanchez, Sr.! Dr. Chavez Sanchez has won a trip ...

Location

Category

Telephone

Address


The Woodlands, TX
77393

Opening Hours

Monday 8am - 6pm
Tuesday 8am - 6pm
Wednesday 8am - 6pm
Thursday 8am - 6pm
Friday 8am - 6pm